Exchange: NASDAQ·Updated 03:55 PM EDT
News
all
press releases
Why Is NervGen Pharma Stock Gaining Tuesday?
NGEN stock climbs as NervGen Pharma NVG-291 hits a 100% responder rate in spinal cord injury gait analysis. Phase 3 set for mid-2026.read more...
Benzinga
NervGen Pharma Appoints Adam Rogers As CEO
(RTTNews) - NervGen Pharma Corp. (NGEN), Monday announced the appointment of Adam Rogers as President and Chief Executive Officer of the company, effective immediately...
Nasdaq News: Markets

Advertisement|Remove ads.